EPCS · remote-care requirements
Electronic prescribing for controlled substances is a security and records framework. It does not itself authorize a telemedicine encounter, establish state prescribing authority or make a prescription clinically appropriate.
What the federal EPCS source covers
DEA’s Diversion Control Division explains that electronic prescriptions for controlled substances are optional under the federal EPCS framework and that compliant practitioner and pharmacy applications may create, transmit, receive, dispense and archive those prescriptions.
The current Q&A describes application audit or certification, identity proofing, logical access controls, two-factor authentication, prescription review and electronic records. It also says practitioners must follow applicable state, local and tribal law.
EPCS is one layer of remote prescribing
- The encounter and prescribing pathway must be permitted.
- The practitioner must have current professional and DEA authority.
- The EPCS applications and authentication workflow must meet requirements.
- The prescription must satisfy federal and applicable state rules.
- The pharmacy must receive and process the electronic record lawfully.
A certified application can support a lawful electronic prescription. It cannot decide whether the telemedicine evaluation, practitioner, patient location or medication qualifies.
What not to infer
Electronic transmission is not evidence that no examination was required. It is also not a guarantee that a pharmacy will dispense, an insurer will pay or a clinician will prescribe. Those outcomes depend on separate legal, clinical and operational facts.
What organizations can verify next
Review the current DEA EPCS Q&A and 21 CFR parts cited there, obtain the application’s audit or certification information and check state requirements. This article does not certify software or offer a compliance conclusion.